| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.5 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.019 | 0.5 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.5 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |